DIA Labs is transforming asthma care with AirSense, an affordable and comfortable wearable device designed for continuous, real-time monitoring. Backed by provincial-level funding, AirSense provides accurate lung function data that integrates seamlessly with smartphones, empowering patients to stay in control of their condition. Its advanced AI-driven insights help predict asthma flare-ups, offering timely interventions. Not only is AirSense improving daily asthma management, but it’s also providing precise, real-world data that will be invaluable for advancing clinical trials. DIA Labs is committed to delivering innovative, cost-effective solutions for better respiratory health.